CEO-Yaniv Dolev, DVM, MBA

Yaniv is a seasoned entrepreneur with a focus on early stage life science technologies. He has 12 years of experience in founding start-ups for translational research for promising novel medical technologies. His accomplishments include founding Moebius Medical in 2008, based on technology licensed from Hebrew University and the Technion. During his time at Moebius Medical, Yaniv led development of the company’s lead drug through its early in vivo proof-of-concept, complete non-clinical studies, and successful clinical trials, as well as fundraising, culminating in an exclusive global licensing deal with Sun Pharma in December 2016. Yaniv excels in both processing and maturing complex innovative ideas to define effective products that can answer a market need while also managing corporate development including fundraising, strategy building, business development and marketing. Yaniv is a veterinary surgeon and has an MBA.